期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺动脉高压诊治中值得注意的几个问题 被引量：7

原文传递
导出
摘要 近10年来我国肺动脉高压的研究蓬勃发展，取得了长足进展。临床医师对肺动脉高压的诊治水平有所提高，令人欣慰，但在对肺动脉高压的认识及诊治中仍存在不少问题或误区。现就其中一些主要问题阐述如下，希冀同行们批评指正。
作者 熊长明
机构地区 中国医学科学院国家心血管病中心北京阜外心血管病医院肺血管病诊治中心
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第40期3172-3174,共3页 National Medical Journal of China
关键词 肺动脉高压 诊治 临床医师
分类号 R543.2 [医药卫生—心血管疾病]
  • 相关文献

参考文献18

  • 1Aronson JK. Rare diseases and orphan drugs. Br J Clin Pharmacol, 2006, 61: 243-245.
  • 2Galio N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J, 2009, 30:2493-2537.
  • 3D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med, 1991, 115:343-349.
  • 4Oya H, Nagaya N, Uematsu M, et al. Poor prognosis and related factors in adults with Eisenmenger syndrome. Am Heart J, 2002, 143 : 739-744.
  • 5Cantor WJ, Harrison DA, Moussadji JS, et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol, 1999, 84: 677-681.
  • 6胡盛寿,朱晓东,郭加强,吴学军,薛淦兴.先天性心脏病合并重度肺动脉高压的临床分级再讨论──314例远期疗效的随访研究[J].中国循环杂志,1995,10(3):151-154. 被引量：36
  • 7Zeng WJ, Sun Y J, Gu Q, et al. The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension. Pu|m Circ, 2012, 2: 373-378.
  • 8Benza RL, Miller DP, Barst RJ, et al. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest, 2012, 142: 448456.
  • 9董琳,何建国,柳志红,卢献灵,曾伟杰,孙云娟,倪新海,顾晴,赵智慧,程显声,熊长明.成人肺动脉高压疾病特征的多中心临床研究[J].中华医学杂志,2012,92(16):1087-1090. 被引量：17
  • 10Hoeper MM, Lee SH, Voswincke R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coil Cardiol, 2006, 48 : 2546-2552.

二级参考文献26

  • 1Paciocco G, Martinez FJ, Bossone E, et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J, 2001, 17:647-652.
  • 2Camargo VM, Martins Bdo C, Jardim C, et al. Validation of a treadmill six-minute walk test protocol for the evaluation of patients with pulmonary arterial hypertension. J Bras Pneumol, 2009, 35 : 423 -430.
  • 3Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology ( ESC ), European Respiratory Society (ERS), International Society of Heart and Lung Transplantation (ISHLT) , et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J, 2009, 34: 1219-1263.
  • 4McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation TaskForce on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association. J Am Coil Cardiol, 2009, 53:1573-1619.
  • 5McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines. Chest, 2004, 126 : 14S-34S.
  • 6Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the Eurppean Society of Cardilogy. Eur Heart J, 2004, 25: 2243- 997R.
  • 7ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six- minute walk test. Am J Respir Crit Care Med, 2002, 166: 111- 117.
  • 8Berger RM, Beghetti M, Gali~ N, et al. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo- controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis. Int J Cardiol, 2010, 144:373-378.
  • 9Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest, 2007, 132: 373-379.
  • 10Thenappan T, Shah SJ, Rich S, et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J, 2007, 30: 1103-1110.

共引文献56

同被引文献46

  • 1D'Alonzo GE,Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry [ J]. Ann Intern Med, 1991,115 : 343-349.
  • 2McLaughlin VV, Suissa S. Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases [ J]. Circulation ,2010,122 : 106-108.
  • 3Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension [ J ]. J Am Coil Cardiol, 2013,62: D34-D41.
  • 4Gali N, Corris PA, Frost A, et al. Updated treatment algorithm of pulmonary arterial hypertension [ J]. J Am Coil Cardio1,2013,62: D60-D72.
  • 5McLaughlin VV, Gaine SP, Howard I, et al. Treatment goals of pulmonary hypertension [ J ]. J Am Coil Cardiol, 2013,62 : D73- D81.
  • 6Ghofrani HA, D'Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension [ J 1. N Engl J Med,2013,369: 319-329.
  • 7Rubin LJ, Badesch DB, Fleming TR, et al. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study [ J ]. Chest,2011,140 : 1274-1283.
  • 8Gali: N, Bruudage BH, Ghofrani HA, et al. Tadalafil therapy for pulmonary arterial hypertension [ J ]. Circulation, 2009, 119 : 2894-2903.
  • 9Jenkins DP, Madani M, Mayer E, et al. Surgical treatment of chronic thromboembolic pulmonary hypertension [ J ]. Eur Respir J,2013,41 : 735-742.
  • 10Li YD, Zhai ZG, Wu YF, et al. Improvement of right ventricular dysfunction after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension : utility ofechocardiography to demonstrate restoration of the right ventricle during 2-year follow-up [ J]. Thromb Res,2013,131 : e196-e201.

引证文献7

二级引证文献39

中华医学杂志
2013年 第40期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部